Laser Auriculotherapy for the Treatment of Low Back Pain

Launched by MARCELO NEUBAUER DE PAULA · Jun 5, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called Laser Auriculotherapy to see if it can help relieve low back pain after just one session. The researchers are looking to find out not only if this treatment works better than no treatment at all but also how long the pain relief lasts and how much patients' pain tolerance improves. Participants will be assessed using different scales to measure their pain before and after the treatment, and they will keep track of their pain levels over a week to see how well the treatment helps.

To join the trial, participants need to be between 18 and 65 years old and currently experiencing low back pain. They should also be able to understand the study procedures. However, people with certain conditions, like ear deformities or tattoos in the treatment area, won't be eligible. Throughout the trial, participants will be monitored for any side effects or issues related to the treatment to ensure their safety. Overall, this study aims to provide more options for those suffering from low back pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant capable of understanding and performing all procedures and instructions described in the Informed Consent Form approved by the Research Ethics Committee;
• • Participants of both sexes, aged between 18 and 65 years (inclusive);
• • Participants diagnosed with low back pain who are in pain at the time of the assessment
• Exclusion Criteria:
• • Any clinical observation finding (clinical/physical evaluation) that is interpreted by the investigating physician as a risk to participation in the clinical trial;
• • Patient with a deforming lesion on the ear
• • Patient with a tattoo covering any of the points selected for treatment
• • Patients using ear expanders on the side to be treated
• • Research participants who have participated in clinical trial protocols in the last 12 (twelve) months (Brazilian National Health Council Resolution 251, of August 7, 1997), unless the investigator believes that there may be direct benefit to the same.